Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
Yongxian Hu(Zhejiang Chinese Medical University), Yali Zhou(Wenzhou Medical University), Mingming Zhang(Zhejiang Lab), Houli Zhao(Zhejiang Lab), Guoqing Wei(Zhejiang Lab), Wengang Ge, Qu Cui(Capital Medical University), Qitian Mu(Ningbo First Hospital), Gong Chen, Lu Han, Tingting Guo, Jiazhen Cui(Zhejiang Lab), Xiaoyan Jiang, Xiujun Zheng, Shuhui Yu, Xiaolong Li, Xingwang Zhang, Mingxi Chen, Xiuju Li, Ming Gao, Kang Wang, Cheng Zu(Zhejiang Lab), Hao Zhang(Wenzhou Medical University), Xiaohong He, Yanbin Wang, Dongrui Wang(Zhejiang Chinese Medical University), Jiangtao Ren(Viva Biotech (China)), He Huang(Zhejiang Lab)
Cited by 187Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis